Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2013-09-06 Regulatory Filings
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
Information relative au nombre total de droits de vote et d'actions composant le capital
Regulatory Filings Classification · 85% confidence The document is a short regulatory disclosure under Article 223-16 of the French AMF rules, listing the company’s total shares (‘Actions du capital’) and voting rights (‘Droits de vote théoriques’) as of a cut-off date, along with self‐held shares. It is not announcing a report nor providing financial results, nor is it a major shareholder threshold notification or share issue. It is a general regulatory announcement that does not fit other specific categories, making ‘Regulatory Filings’ (RNS) the appropriate classification.
2013-09-06 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Regulatory Filings Classification · 95% confidence The document is very short (831 characters) and appears to be a formal regulatory disclosure based on the reference to 'ARTICLE 223-16 du règlement général de l'AMF' (French Financial Markets Authority). It details capital structure information, specifically the total number of shares and voting rights, and mentions 'Actions privées de droits de vote' (Shares deprived of voting rights). This type of mandatory disclosure regarding share capital structure and voting rights, especially when short and regulatory-focused, often falls under general regulatory announcements or specific capital structure updates. Since it is not a full report (like 10-K or IR) and doesn't explicitly announce a dividend (DIV) or a major share transaction (POS/SHA), the most appropriate general category for a mandatory regulatory filing detailing capital structure mechanics is 'Regulatory Filings' (RNS), as it is a specific regulatory disclosure that doesn't fit the other detailed categories perfectly, although it touches upon capital structure elements. Given the context of AMF regulation and capital structure data, RNS is the best fit as a general regulatory filing.
2013-09-06 French
First-half 2013 turnover
Earnings Release Classification · 95% confidence The document is a press release dated July 18, 2013, announcing the financial data for the second quarter and first half of 2013 for METabolic EXplorer. It provides key turnover figures, cash position as of June 30, 2013, and general company information. This format, focusing on key highlights for a specific reporting period (quarterly/half-yearly) without the comprehensive detail of a full annual report (10-K) or a detailed management discussion (MDA), aligns best with an Earnings Release (ER). Although it covers the first half, it is presented as an initial announcement of results, not a comprehensive 'Interim Report' (IR), which usually implies a more structured financial statement filing. Given the brevity and focus on key figures immediately following the period end, ER is the most appropriate classification. H1 2013
2013-07-18 English
Chiffre d'affaires au 1er semestre 2013
Earnings Release Classification · 98% confidence The document is titled "METabolic EXplorer: Chiffre d'affaires au 1er semestre 2013" and explicitly states it publishes its "information financière du 2ème trimestre 2013" (financial information for the 2nd quarter of 2013). It presents key financial figures, specifically revenue (chiffre d'affaires) for the first half of the year (1er semestre) and the second quarter (2ème trimestre), along with cash position as of June 30, 2013. This content structure—a brief announcement focusing on key financial metrics for a period shorter than a full year—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it focuses on the quarterly revenue highlights and cash position rather than being a comprehensive, detailed report (like a 10-Q or IR), it aligns best with the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). The document length (3490 chars) also supports this being a summary announcement rather than a full report. H1 2013
2013-07-18 French
Bilan du contrat de liquidité
Share Issue/Capital Change Classification · 99% confidence The document is titled "METabolic EXplorer : Bilan du contrat de liquidité" (Balance of the Liquidity Contract) and provides a semi-annual update (as of June 30, 2013) on the assets held under a liquidity contract managed by CM-CIC Securities (17,000 shares and €37,605.35 in cash). This type of announcement details the status of share buyback programs or liquidity maintenance agreements, which directly relates to the company's own shares and capital structure management. This fits best under 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities, or potentially 'Capital/Financing Update' (CAP). Given the specific focus on the liquidity contract balance, POS is the most precise fit, as liquidity contracts are mechanisms for managing share price stability, often involving share transactions or setting aside funds for them. It is not a general financing update (CAP) but a specific report on share management activity.
2013-07-03 French
Compte-rendu de l'Assemblée Générale Mixte 2013
AGM Information Classification · 99% confidence The document title explicitly states "METabolic EXplorer : Compte-rendu de l'Assemblée Générale Mixte 2013" (Minutes/Report of the Combined General Meeting 2013). The text details the results of the Ordinary and Extraordinary General Meeting (Assemblée Générale Ordinaire et Extraordinaire), including the adoption of resolutions, voting results, and responses to shareholder questions. This content directly corresponds to the materials presented or summarized from an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2013-06-24 French

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.